Clinical and molecular analysis of the enamelin gene ENAM in Colombian families with autosomal dominant amelogenesis imperfecta
AUTOR(ES)
Gutiérrez, Sandra, Torres, Diana, Briceño, Ignacio, Gómez, Ana Maria, Baquero, Eliana
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
2012
RESUMO
In this study, we analyzed the phenotype, clinical characteristics and presence of mutations in the enamelin gene ENAM in five Colombian families with autosomal dominant amelogenesis imperfecta (ADAI). 22 individuals (15 affected and seven unaffected) belonging to five Colombian families with ADAI and eight individuals (three affected and five unaffected) belonging to three Colombian families with autosomal recessive amelogenesis imperfecta (ARAI) that served as controls for molecular alterations and inheritance patterns were studied. Clinical, radiographic and genetic evaluations were done in all individuals. Eight exons and three intron-exon boundaries were sequenced for mutation analysis. Two of the five families with ADAI had the hypoplasic phenotype, two had the hypocalcified phenotype and one had the hypomaturative phenotype. Anterior open bite and mandibular retrognathism were the most frequent skeletal abnormalities in the families with ADAI. No mutations were found. These findings suggest that ADAI in these Colombian families was unrelated to previously described mutations in the ENAM gene. These results also indicate that other regions not included in this investigation, such as the promoter region, introns and other genes should be considered as potential ADAI candidates.
Documentos Relacionados
- Diversity of clinical, radiographic and genealogical findings in 41 families with amelogenesis imperfecta
- Analysis of known gene for enamed development in families with amelogenesis imperfecta
- A syndrome of epilepsy, dementia, and amelogenesis imperfecta: genetic and clinical features.
- DNA microsatellite analysis of families with autosomal dominant polycystic kidney disease types 1 and 2: evaluation of clinical heterogeneity between both forms of the disease.
- Clinical, cytogenetic, and molecular analysis of three families with FRAXE.